Company / Accounts Receivable
ARVINAS, INC. Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.0M
FY2025
5-year range
$0 / $15.0M
FY2021-FY2025
Trend
-82.5%
vs FY2024
Sector context
#105 of 113
Health Care
What the data says
Among 113 Health Care companies, ARVINAS, INC. is in the bottom 7% for accounts receivable. Accounts Receivable has fluctuated over the past 8 years, ranging from $0 in FY2023 to $25M in FY2017.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +0.0%.
Improved from $0 to $1M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -59.5%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 113This company $1.0M Sector average $1.1B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2025, accounts receivable decreased 82.5% year-over-year.
- Ranks #105 out of 113 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0M | -82.5% |
| FY2024 | $5.7M | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $15.0M | +1400.0% |
| FY2021 | $1.0M | +0.0% |
| FY2020 | $1.0M | - |
| FY2019 | - | - |
| FY2018 | $2.8M | -88.9% |
| FY2017 | $25.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026